Latest Antivirals Stories
EDISON, N.J., Dec. 9, 2014 /PRNewswire/ -- ContraVir Pharmaceuticals, Inc.
- Major regulatory milestone achieved toward approval in the European Union NORTH CHICAGO, Ill., Nov.
- In adult patients co-infected with genotype 1 (GT1) hepatitis C virus (HCV) infection and human immunodeficiency virus (HIV) type 1 infection, TURQUOISE-I demonstrated sustained virologic response
- Results demonstrated high response rates in adult chronic hepatitis C genotype 4 patients without cirrhosis BOSTON, Nov.
--Expanded indication includes both treatment-naive and treatment-experienced adult patients with or without cirrhosis-- TITUSVILLE, N.J., Nov.
Forum uniquely brings together leading family offices and their foundations seeking impact investment, grant-giving, and philanthropy opportunities within health and life sciences EDISON,
ResolveHerpes is an All-Natural Mineral Detox Product that Helps to Remove Herpes from the Body Mandeville, LA (PRWEB) October 23, 2014 Resolve Herpes,
FLINT, Mich., Oct. 22, 2014 /PRNewswire/ -- U.S.
MOSCOW, October 21, 2014 /PRNewswire/ -- Hepatera Ltd and its development partner MYR GmbH announced today the results of clinical trials investigating Myrcludex B in patients
EDISON, N.J., Oct. 16, 2014 /PRNewswire/ -- ContraVir Pharmaceuticals, Inc.
- A person in a secondary role, specifically the second most important character (after the protagonist).